Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1517796

Rangeley Capital, LLC

Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$107.5M
Reported positions
176
Holdings vs S&P 500, 3 yrs
—
Assets under management
$220.5M

Rangeley Capital, LLC is a hedge fund that reported 176 positions worth $107.5M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Driven Brands Hldgs Inc (DRVN, 6.7%), Revolution Medicines Inc (RVMDW, 4.4%), Prothena Corp PLC Shs (PRTA, 3.8%).

Rangeley Capital, LLC holdings largest 50 of 176 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Rangeley Capital, LLC 13F holdings
Stock% of 13F valueShare changeReported value
DRVNDriven Brands Hldgs Inc6.7%-17.1%$7.2M
RVMDWRevolution Medicines Inc4.4%—$4.7M
PRTAProthena Corp PLC Shs3.8%-7.2%$4.1M
SEGSeaport Entmt Group Inc3.8%+0.0%$4.1M
GRNDGrindr Inc2.9%-6.0%$3.2M
STHOStar Hldgs2.8%+18.4%$3.0M
FLLFull Hse Resorts Inc2.4%+1.1%$2.6M
ABUSArbutus Biopharma Corp2.2%+0.0%$2.4M
TRIPTripadvisor Inc1.9%-20.0%$2.1M
ECHOEchoStar Corp1.7%-1.1%$1.8M
ABVXAbivax SA1.6%+225.0%$1.7M
GDOTGreen Dot Corp1.6%-21.6%$1.7M
LAWSDistribution Solutions Grp I1.6%+273.7%$1.7M
TBPHTheravance Biopharma Inc1.6%-3.4%$1.7M
RLYBRallybio Corp1.6%—$1.7M
ONLOrion Properties Inc1.6%-36.8%$1.7M
MNROMonro Inc1.5%+84.4%$1.7M
RVMDRevolution Medicines Inc1.5%-87.0%$1.6M
BHFBrighthouse Finl Inc1.5%+0.0%$1.6M
JANXJanux Therapeutics Inc1.4%-20.0%$1.5M
NOMDNomad Foods Ltd1.4%—$1.5M
ARVNArvinas Inc1.4%-21.6%$1.5M
DKDelek US Hldgs Inc New1.3%-55.0%$1.4M
WBDWarner Bros Discovery Inc1.3%+0.0%$1.4M
ZIMZim Integrated Shipping Serv1.3%-5.5%$1.4M
MLAAMountain Lake Acquisition Corp1.2%—$1.3M
EVCEntravision Communications C1.1%—$1.2M
RPDRapid7 Inc1.1%—$1.2M
BCYCBicycle Therapeutics PLC1.0%+9.1%$1.1M
NLOPNet Lease Office Properties1.0%-17.3%$1.1M
KURAKura Oncology Inc1.0%-7.1%$1.0M
WLFCWillis Lease Finance Corp0.9%—$915K
WENNWen Acquisition Corp0.8%+3.7%$897K
DOMODomo Inc0.8%—$864K
METAMeta Platforms Inc0.8%—$845K
RYAMRayonier Advanced Matls Inc0.8%—$824K
IMMRImmersion Corp0.7%—$745K
FWRDForward Air Corp0.7%-35.3%$743K
INMDInmode Ltd0.7%—$731K
DDIDoubledown Interactive Co Lt0.7%—$700K
CLMTCalumet Inc0.6%-64.2%$684K
XPOFXponential Fitness Inc0.6%—$675K
CHTRCharter Communications Inc0.6%—$640K
BCARD Boral Arc Acquisition I Cl A Ord0.6%—$638K
AXINAxiom Intelligence-Cl A0.6%—$633K
DRDBRoman Dbdr Acquisition Corp0.6%+0.0%$632K
GOGrocery Outlet Hldg Corp0.6%—$629K
PAHCPhibro Animal Health Corp0.6%—$628K
CCIICohen Circle Acquisit Corp I0.6%—$616K
YEXTYext Inc0.6%—$609K

What Rangeley Capital, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
-10.2% /yr
S&P 500 +11.7%
3 years
—
5 years
—

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$107.5M176
Q1 2026$92.6M133
Q4 2025$116.1M115
Q3 2025$106.5M121
Q2 2025$79.7M70
Q1 2025$88.6M71
Q4 2024$105.0M71

Questions about Rangeley Capital, LLC's portfolio

What stocks does Rangeley Capital, LLC own?

Rangeley Capital, LLC's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 176 positions worth $107.5M. The largest are Driven Brands Hldgs Inc (DRVN) at 6.7%, Revolution Medicines Inc (RVMDW) at 4.4%, Prothena Corp PLC Shs (PRTA) at 3.8%, Seaport Entmt Group Inc (SEG) at 3.8% and Grindr Inc (GRND) at 2.9%.

What did Rangeley Capital, LLC buy last quarter?

In Q2 2026, Rangeley Capital, LLC added Distribution Solutions Grp I (LAWS) (+273.7% shares), Abivax SA (ABVX) (+225.0% shares) and Monro Inc (MNRO) (+84.4% shares), compared with its Q1 2026 filing.

What did Rangeley Capital, LLC sell last quarter?

In Q2 2026, Rangeley Capital, LLC cut from its top 50 Leggett & Platt Inc (LEGT), cut from its top 50 Icon Plc (ICLR), cut from its top 50 Kezar Life Sciences Inc (KZR), cut from its top 50 Mister Car Wash Inc (MCW), cut from its top 50 Elme Communities (WRE), Revolution Medicines Inc (RVMD) (-87.0% shares), Calumet Inc (CLMT) (-64.2% shares) and Delek US Hldgs Inc New (DK) (-55.0% shares), compared with its Q1 2026 filing.

When is Rangeley Capital, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Rangeley Capital, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Rangeley Capital, LLC manage?

Rangeley Capital, LLC reported $220.5M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $107.5M.